UKALL 2003 (Version 7, August 2009)


N.B. Archived versions of UK ALL2003 documents can still be accessed.

Results June 2012

UKALL2003 closed on 30 June 2011

Recruitment to UKALL 2003 closed on 30/06/2011 although the trial will remain open to follow-up for 3 years from that date. The amendment includes changes to the IMP status of 10 mg 6 MP tablets and MTX suspension as described in the application form.

December 2010

  • UKALL 2003 extended to June 2011

For MREC acknowledgement letter please click here

April 2010

  • UKALL 2003 extended until 30 November 2010

For MREC approval, please click here

  • Revised recommendation for transplantation in patients with iAMP21

For details of the above changes, please click here



Patient Information & Consent Forms

Serious Adverse Event Reporting


Flow Charts


Annual Reports

New Centres


Note: the web page contains some very useful information for parents about the trial. Select "children's" or "children's - leukaemia and lymphoma" from the drop down menu on the search engine.


Back to research page